to-BBB is a clinical stage biotechnology company focusing on enhanced drug delivery across the blood-brain barrier. The Company is developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases, by combining existing drugs with the G-Technology®, to-BBB's proprietary brain delivery platform.
Meet us at
International Liposome Society 2013 Meeting - London
» 14 December 2013
JP Morgan Healthcare Conference 2014 - San Francisco
» 13 January 2014
Hello HollandBIO - Amsterdam
» 29 January 2014